|
Nov 30
|
Lexicon Enrolls First Patient in Phase 2b Progress Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP)
|
|
Oct 11
|
Lexicon's (LXRX) Inpefa Gets Preferred Status at Express Scripts
|
|
Oct 11
|
Data Demonstrating Financial Impact of INPEFA® (Sotagliflozin) to be Presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 National Meeting
|
|
Oct 10
|
Why Shares of Lexicon Pharmaceuticals Are Up Tuesday
|
|
Oct 10
|
Midday movers: PepsiCo, Unity, Rivian Automotive and more
|
|
Oct 10
|
Lexicon Pharma shares rise after Inpefa gets preferred status at Express Scripts
|
|
Oct 9
|
INPEFA® (Sotagliflozin) Receives Preferred Formulary Status With Express Scripts For Medicare Patients
|
|
Oct 9
|
Tom Garner Joins Lexicon as Senior Vice President and Chief Commercial Officer
|
|
Sep 28
|
Lexicon to Present Post Hoc Analysis of Scored Clinical Trial at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2023
|
|
Aug 17
|
10 Healthcare Stocks with Insider Buying
|
|
Apr 28
|
Lexicon Pharmaceuticals to Host First Quarter 2023 Financial Results Conference Call and Webcast on May 2, 2023
|
|
Apr 22
|
Should You Buy This Growth Stock Right Now Before It Potentially Doubles?
|